File:Mainz.BioNTechSE.20200731.jpg · Wikimedia Commons · See Wikimedia Commons
بیوانتک
Sign in to saveAlso known as Biopharmaceutical New Technologies, Biontech, BioNTech SE, BioNTech AG, BNT, BNTX, BionTech
BioNTech SE ( ; or short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
OverviewAI-generated
BioNTech SE, also known as Biopharmaceutical New Technologies, is an active company established in 2008. Headquartered in Mainz, Germany, the organization operates within the biological products industry. It is listed on the Nasdaq exchange under the ticker symbol BNTX.
The company employs 1,300 people and maintains a total asset value of 797,647,000. Its financial records indicate a total revenue of 127,575,000, alongside various net profit figures including -179,172,000, -47,662,000, and -85,950,000. Operating income has also varied, with recorded amounts of -181,518,000, -53,854,000, and -61,277,000.
Synthesized by Vinony from 38 facts across 6 sources: Wikidata, GLEIF, SEC EDGAR, ROR, Firecrawl, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company.name
- BioNTech SE
- Company.logo
- BioNTech logo.svg
- Company.image
- Mainz.BioNTechSE.20200731.jpg
- Company.image_caption
- Headquarters in Mainz
- Company.type
- Public company
- Company.industry
- Biotechnology
- Company.hq_location_city
- Mainz
- Company.hq_location_country
- Germany
- Company.num_locations
- 17
- Company.num_locations_year
- 2024
- Company.area_served
- Worldwide
- Company.products
- Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates
- Company.services
- Immunotherapy
- Company.revenue
- billion
- Company.revenue_year
- 2025
- Company.operating_income
- €−1.40 billion
- Company.income_year
- 2025
- Company.net_income
- €−1.14 billion
via Wikipedia infobox
Company
BNTX- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- 2M
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
- Jurisdiction
- DE
- Headquarters
- Mainz, DE
Research organization · ROR
- Type
- Company
- Founded
- 2008
- Location
- Mainz, Germany
- Also known as
- Biopharmaceutical New Technologies
- Status
- Active
GRID grid.434484.b · ISNI 0000 0004 4692 2203
Official website
BioNTech
BioNTech führt Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.
biontech.de →Link to the official site · 10,522 chars · not written by Vinony
Wikidata facts
- Instance of
- enterprise
- Official name
- BioNTech AG
- Country
- Germany
- Founded by
- Uğur Şahin
- Headquarters
- Mainz
- CEO
- Uğur Şahin
- Industry
- pharmaceutical industry
- Employees
- 1300
- Revenue
- 61598000
- Stock exchange
- Nasdaq
- Legal form
- Societas Europaea
- Country of origin
- Germany
- Official website
- biontech.de
- Image
- Mainz.BioNTechSE.20200731.jpg
Show 13 more facts
- inception
- 2008-06-00
- Commons category
- BioNTech
- significant person
- Katalin Karikó
- on focus list of Wikimedia project
- WikiProject COVID-19
- net profit
- -85950000
- total assets
- 374713000
- board member
- Uğur Şahin
- operating income
- -61277000
- total equity
- -48206000
- product or material produced
- Pfizer–BioNTech COVID-19 vaccine
- topic's main category
- Category:BioNTech
- social media followers
- 82448
- location of formation
- Mainz
Sources (8)
via Wikidata · CC0
Gallery (3)
On the map
14 mapped locations